Medications can affect cancer risk; menopausal hormone therapy can for instance influence the risk of breast and ovarian cancer. The aim of the project is to study associations between medication use and the risk of cancer and prognosis after a cancer diagnosis.
HPV-SEQ is an cross-institutional research group with the main goals: 1) To discover HPV biomarkers 2) To delineate HPV evolution 3) To develop HPV detection and characterization methods. We take advantage of Next Generation Sequencing (NGS) Technology to reach our goals.
Small noncoding RNAs (sncRNA) are involved in numerous cellulary processes in cancer development. We are currently investigating sncRNA as early detection and potential screening biomarkers of cancer.
NORCCAP (Norwegian Colorectal Cancer Prevention) is a randomized study on screening for colorectal cancer (CRC) and adenomatous polyps (potential precursor lesions for colorectal cancer). The project arose from an initiative made by the Norwegian Gastrointestinal Cancer Group (NGICG) and the Norwegian Cancer Society with funding from the Norwegian Cancer Society and the Ministry of Health and Social Affairs.